1. Monteiro, Filipe A, Miranda, Rafael M, Samina, Marta C, Castro, Diogo S, Lima, Deolinda. 2021. Tlx3 Exerts Direct Control in Specifying Excitatory Over Inhibitory Neurons in the Dorsal Spinal Cord. In Frontiers in cell and developmental biology, 9, 642697. doi:10.3389/fcell.2021.642697. https://pubmed.ncbi.nlm.nih.gov/33996801/
2. Ma, Jiexian, Hua, Jinsheng, Sha, Yinghao, Xie, Yanhui. 2014. The effect of TLX3 expression on the prognosis of pediatric T cell acute lymphocytic leukemia--a systematic review. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35, 8439-43. doi:10.1007/s13277-014-1873-5. https://pubmed.ncbi.nlm.nih.gov/24997618/
3. Urrutia, Hugo A, Stundl, Jan, Bronner, Marianne E. 2024. Tlx3 mediates neuronal differentiation and proper condensation of the developing trigeminal ganglion. In Developmental biology, 515, 79-91. doi:10.1016/j.ydbio.2024.07.005. https://pubmed.ncbi.nlm.nih.gov/39019425/
4. Wang, Cong, Dou, Changwei, Wang, Yufeng, Roberts, Lewis, Zheng, Xin. 2019. TLX3 repressed SNAI1-induced epithelial-mesenchymal transition by directly constraining STAT3 phosphorylation and functionally sensitized 5-FU chemotherapy in hepatocellular carcinoma. In International journal of biological sciences, 15, 1696-1711. doi:10.7150/ijbs.33844. https://pubmed.ncbi.nlm.nih.gov/31360112/
5. Lauwereins, Lukas, Van Thillo, Quentin, Demeyer, Sofie, Cools, Jan, Veloso, Alexandra. 2025. TLE4 is a repressor of the oncogenic activity of TLX3 in T-cell acute lymphoblastic leukemia. In Leukemia, 39, 568-576. doi:10.1038/s41375-025-02513-w. https://pubmed.ncbi.nlm.nih.gov/39838044/